Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042010
Filing Date
2019-11-08
Accepted
2019-11-08 07:11:45
Documents
101
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q reph-10q_20190930.htm 10-Q 2510001
2 EX-10.1 reph-ex101_73.htm EX-10.1 180092
3 EX-31.1 reph-ex311_7.htm EX-31.1 17164
4 EX-31.2 reph-ex312_8.htm EX-31.2 17172
5 EX-32.1 reph-ex321_6.htm EX-32.1 7935
  Complete submission text file 0001564590-19-042010.txt   10877023

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT reph-20190930.xml EX-101.INS 2531040
7 XBRL TAXONOMY EXTENSION SCHEMA reph-20190930.xsd EX-101.SCH 84068
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reph-20190930_cal.xml EX-101.CAL 70323
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reph-20190930_def.xml EX-101.DEF 273033
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE reph-20190930_lab.xml EX-101.LAB 625390
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reph-20190930_pre.xml EX-101.PRE 486654
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

EIN.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36329 | Film No.: 191202063
SIC: 2834 Pharmaceutical Preparations